Filtered By:
Vaccination: Pneomococcal Vaccine
Countries: China Health
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 180 results found since Jan 2013.
A Mini Review on Discovery and Synthesis of Remdesivir as an Effective and Promising Drug against COVID-19
Russ J Bioorg Chem. 2021;47(3):609-621. doi: 10.1134/S1068162021030183. Epub 2021 Jun 11.ABSTRACTThe severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) as a new human coronavirus has begun spreading over Wuhan City/China in December 2019, and then spread rapidly worldwide, causing pneumonia called COVID-19. Up to now, the scientists have extensively attempted to find effective vaccines and drugs for treatment of coronavirus infections. To this end, various pharmaceutical agents are undergoing the clinical studies to assess their potency and efficacy against COVID-19. Based on the new findings, the U.S. food and d...
Source: Bioorganic Chemistry - June 21, 2021 Category: Chemistry Authors: E Zarenezhad S Behrouz M Farjam M N Soltani Rad Source Type: research
Fight Aging! Newsletter, June 14th 2021
In conclusion, a number of high-income countries, changes in health expectancies over time have not kept pace with the growth in life expectancy. That is, people are living longer but disability and poor health are occupying an increasing proportion of later life. Our findings suggest that countries still need to make significant progress to achieve the WHO's Decade of Healthy Ageing goal of healthier, longer lives for all.
Progress on Understanding Why Human Growth Hormone Receptor Variants are Associated with Greater Longevity
https://www.fightaging.org/archives/2021/06/progress-on-understanding-why-human-gro...
Source: Fight Aging! - June 13, 2021 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
One cross-sectional investigation revealed that non-vaccine serotypes of Streptococcus pneumoniae could be identified more frequently in elderly Chinese people
CONCLUSION: The PCV13 coverage rate in pediatric isolates was higher than those in adult isolates. The adults, especially the elderly, may be the reservoir of non-PCV13 types. It is necessary to investigate the serotype distribution of S. pneumoniae based on all age population to assess potential epidemics of non-vaccine serotype associated with PCVs administration.PMID:33980399 | DOI:10.1016/j.vaccine.2021.02.053
Source: Vaccine - May 13, 2021 Category: Allergy & Immunology Authors: Qian-Qian Du Hai-Lin Zeng Lin Yuan Ping Tang Wei Gao Jiao-Jiao Xu Wei Shi Tian Leng Kuan-Xiu Hu Kai-Hu Yao Source Type: research
Immunogenicity and safety of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 2-5 years in China
CONCLUSIONS: A single dose of PCV7 was immunogenic and safe for Chinese children aged 2-5 years, and the preexisting antibodies against the PCV7 serotypes did not change the response to vaccination. The findingssupported the effectiveness of PCV7 in this age group. PCVs with broader serotype coverage are expected to expand pneumococcal disease protection.PMID:33965257 | DOI:10.1016/j.vaccine.2021.04.037
Source: Vaccine - May 9, 2021 Category: Allergy & Immunology Authors: Jian Wang Shuang Bai Shanshan Zhou Wei Zhao Qin Li Min Lv Peng Zhang Haizhou Zhang Wenwen Lan Yanli Kang Yali Wang Jin Li Xiaotong Gao Xiaomei Tong Jiang Wu Qun Zheng Source Type: research
Clinical characteristics and plasma antibody titer of patients with COVID-19 in Zhejiang, China
J Zhejiang Univ Sci B. 2020 Dec.;21(12):955-960. doi: 10.1631/jzus.B2000593.ABSTRACTCoronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first affected humans in China on December 31, 2019 (Shi et al., 2020). Coronaviruses generally cause mild, self-limiting upper respiratory tract infections in humans, such as the common cold, pneumonia, and gastroenteritis (To et al., 2013; Berry et al., 2015; Chan et al., 2015). According to the Report of the World Health Organization (WHO)-China Joint Mission on COVID-19 (WHO, 2020), the case fatality...
Source: J Zhejiang Univ Sci ... - April 12, 2021 Category: Science Authors: Wei-Ling Xiang Jing-Jing Cheng Lian-Peng Wu Bing-Yu Chen Wen-Xin Li Dan-Ying Qiu Wei Zhang Fei-Hang Ge Dong Chen Zhen Wang Source Type: research
